These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33103428)

  • 21. Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse Model.
    Singh K; Okombo J; Brunschwig C; Ndubi F; Barnard L; Wilkinson C; Njogu PM; Njoroge M; Laing L; Machado M; Prudêncio M; Reader J; Botha M; Nondaba S; Birkholtz LM; Lauterbach S; Churchyard A; Coetzer TL; Burrows JN; Yeates C; Denti P; Wiesner L; Egan TJ; Wittlin S; Chibale K
    J Med Chem; 2017 Feb; 60(4):1432-1448. PubMed ID: 28094524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplasmodial activity of [(aryl)arylsulfanylmethyl]Pyridine.
    Kumar S; Das SK; Dey S; Maity P; Guha M; Choubey V; Panda G; Bandyopadhyay U
    Antimicrob Agents Chemother; 2008 Feb; 52(2):705-15. PubMed ID: 18025110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of 6'-chloro-N-methyl-5'-(phenylsulfonamido)-[3,3'-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium.
    Liang X; Jiang Z; Huang Z; Li F; Chen C; Hu C; Wang W; Hu Z; Liu Q; Wang B; Wang L; Qi Z; Liu J; Jiang L; Liu Q
    Eur J Med Chem; 2020 Feb; 188():112012. PubMed ID: 31911293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemozoin and antimalarial drug discovery.
    Fong KY; Wright DW
    Future Med Chem; 2013 Aug; 5(12):1437-50. PubMed ID: 23919553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemozoin inhibiting 2-phenylbenzimidazoles active against malaria parasites.
    L'abbate FP; Müller R; Openshaw R; Combrinck JM; de Villiers KA; Hunter R; Egan TJ
    Eur J Med Chem; 2018 Nov; 159():243-254. PubMed ID: 30296683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.
    Ramachandran S; Hameed P S; Srivastava A; Shanbhag G; Morayya S; Rautela N; Awasthy D; Kavanagh S; Bharath S; Reddy J; Panduga V; Prabhakar KR; Saralaya R; Nanduri R; Raichurkar A; Menasinakai S; Achar V; Jiménez-Díaz MB; Martínez MS; Angulo-Barturen I; Ferrer S; Sanz LM; Gamo FJ; Duffy S; Avery VM; Waterson D; Lee MC; Coburn-Flynn O; Fidock DA; Iyer PS; Narayanan S; Hosagrahara V; Sambandamurthy VK
    J Med Chem; 2014 Aug; 57(15):6642-52. PubMed ID: 25007124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a softfocus kinase library: part 2.
    Le Manach C; Paquet T; Gonzàlez Cabrera D; Younis Y; Taylor D; Wiesner L; Lawrence N; Schwager S; Waterson D; Witty MJ; Wittlin S; Street LJ; Chibale K
    J Med Chem; 2014 Nov; 57(21):8839-48. PubMed ID: 25313449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum.
    Wicht KJ; Combrinck JM; Smith PJ; Hunter R; Egan TJ
    J Med Chem; 2016 Jul; 59(13):6512-30. PubMed ID: 27299916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility.
    Kato N; Sakata T; Breton G; Le Roch KG; Nagle A; Andersen C; Bursulaya B; Henson K; Johnson J; Kumar KA; Marr F; Mason D; McNamara C; Plouffe D; Ramachandran V; Spooner M; Tuntland T; Zhou Y; Peters EC; Chatterjee A; Schultz PG; Ward GE; Gray N; Harper J; Winzeler EA
    Nat Chem Biol; 2008 Jun; 4(6):347-56. PubMed ID: 18454143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model.
    Booker ML; Bastos CM; Kramer ML; Barker RH; Skerlj R; Sidhu AB; Deng X; Celatka C; Cortese JF; Guerrero Bravo JE; Crespo Llado KN; Serrano AE; Angulo-Barturen I; Jiménez-Díaz MB; Viera S; Garuti H; Wittlin S; Papastogiannidis P; Lin JW; Janse CJ; Khan SM; Duraisingh M; Coleman B; Goldsmith EJ; Phillips MA; Munoz B; Wirth DF; Klinger JD; Wiegand R; Sybertz E
    J Biol Chem; 2010 Oct; 285(43):33054-33064. PubMed ID: 20702404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission.
    Baker DA; Stewart LB; Large JM; Bowyer PW; Ansell KH; Jiménez-Díaz MB; El Bakkouri M; Birchall K; Dechering KJ; Bouloc NS; Coombs PJ; Whalley D; Harding DJ; Smiljanic-Hurley E; Wheldon MC; Walker EM; Dessens JT; Lafuente MJ; Sanz LM; Gamo FJ; Ferrer SB; Hui R; Bousema T; Angulo-Barturén I; Merritt AT; Croft SL; Gutteridge WE; Kettleborough CA; Osborne SA
    Nat Commun; 2017 Sep; 8(1):430. PubMed ID: 28874661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro efficacy of 2,N-bisarylated 2-ethoxyacetamides against Plasmodium falciparum.
    Gutteridge CE; Major JW; Nin DA; Curtis SM; Bhattacharjee AK; Gerena L; Nichols DA
    Bioorg Med Chem Lett; 2016 Feb; 26(3):1048-1051. PubMed ID: 26750257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of β-hematin inhibitors in the MMV Malaria Box.
    Fong KY; Sandlin RD; Wright DW
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):84-91. PubMed ID: 26150923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
    Leung SC; Gibbons P; Amewu R; Nixon GL; Pidathala C; Hong WD; Pacorel B; Berry NG; Sharma R; Stocks PA; Srivastava A; Shone AE; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Hill A; Fisher NE; Warman AJ; Biagini GA; Ward SA; O'Neill PM
    J Med Chem; 2012 Mar; 55(5):1844-57. PubMed ID: 22364417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans.
    Malmquist NA; Sundriyal S; Caron J; Chen P; Witkowski B; Menard D; Suwanarusk R; Renia L; Nosten F; Jiménez-Díaz MB; Angulo-Barturen I; Santos Martínez M; Ferrer S; Sanz LM; Gamo FJ; Wittlin S; Duffy S; Avery VM; Ruecker A; Delves MJ; Sinden RE; Fuchter MJ; Scherf A
    Antimicrob Agents Chemother; 2015 Feb; 59(2):950-9. PubMed ID: 25421480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials.
    Kancharla P; Dodean RA; Li Y; Pou S; Pybus B; Melendez V; Read L; Bane CE; Vesely B; Kreishman-Deitrick M; Black C; Li Q; Sciotti RJ; Olmeda R; Luong TL; Gaona H; Potter B; Sousa J; Marcsisin S; Caridha D; Xie L; Vuong C; Zeng Q; Zhang J; Zhang P; Lin H; Butler K; Roncal N; Gaynor-Ohnstad L; Leed SE; Nolan C; Ceja FG; Rasmussen SA; Tumwebaze PK; Rosenthal PJ; Mu J; Bayles BR; Cooper RA; Reynolds KA; Smilkstein MJ; Riscoe MK; Kelly JX
    J Med Chem; 2020 Jun; 63(11):6179-6202. PubMed ID: 32390431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imidazolopiperazines: hit to lead optimization of new antimalarial agents.
    Wu T; Nagle A; Kuhen K; Gagaring K; Borboa R; Francek C; Chen Z; Plouffe D; Goh A; Lakshminarayana SB; Wu J; Ang HQ; Zeng P; Kang ML; Tan W; Tan M; Ye N; Lin X; Caldwell C; Ek J; Skolnik S; Liu F; Wang J; Chang J; Li C; Hollenbeck T; Tuntland T; Isbell J; Fischli C; Brun R; Rottmann M; Dartois V; Keller T; Diagana T; Winzeler E; Glynne R; Tully DC; Chatterjee AK
    J Med Chem; 2011 Jul; 54(14):5116-30. PubMed ID: 21644570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of carbohybrid-based 2-aminopyrimidine analogues as a new class of rapid-acting antimalarial agents using image-based cytological profiling assay.
    Lee S; Lim D; Lee E; Lee N; Lee HG; Cechetto J; Liuzzi M; Freitas-Junior LH; Song JS; Bae MA; Oh S; Ayong L; Park SB
    J Med Chem; 2014 Sep; 57(17):7425-34. PubMed ID: 25137549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of 4-Amino 2-Anilinoquinazolines against
    Gilson PR; Nguyen W; Poole WA; Teixeira JE; Thompson JK; Guo K; Stewart RJ; Ashton TD; White KL; Sanz LM; Gamo FJ; Charman SA; Wittlin S; Duffy J; Tonkin CJ; Tham WH; Crabb BS; Cooke BM; Huston CD; Cowman AF; Sleebs BE
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
    Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
    PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.